Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Swain

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|July 19, 2005
CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitisFeng Zhou, Maureen N Ajuebor, Paul L Beck, et al.
The American Journal of Gastroenterology|May 8, 2013
B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acidRobert P Myers, Mark G Swain, Samuel S Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2007
Profound suppression of chronic hepatitis C following superinfection with hepatitis B virusCarla S Coffin, Patricia M Mulrooney-Cousins, Samuel S Lee, et al.
Frontiers in Immunology|April 12, 2021
The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the MouseWagdi Almishri, Rachelle P Davis, Abdel-Aziz Shaheen, et al.
The American Journal of Pathology|May 26, 2007
CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitisMaureen N Ajuebor, Zenebech Wondimu, Cory M Hogaboam, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
TNF-alpha-secreting monocytes are recruited into the brain of cholestatic miceSteven M Kerfoot, Charlotte D'Mello, Henry Nguyen, et al.
Hepatology Communications|February 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trialDavid Jones, Marco Carbone, Pietro Invernizzi, et al.
The American Journal of Gastroenterology|April 30, 2021
Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United StatesChristina Thornton, Ranjani Somayaji, Michael Parkins, et al.
Brain, Behavior, and Immunity|August 30, 2021
Behavioural adaptations after antibiotic treatment in male mice are reversed by activation of the aryl hydrocarbon receptorFernando A Vicentini, Alexander J Mathews, Quentin J Pittman, et al.
Plos One|April 5, 2018
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomesAbdel-Aziz Shaheen, Gilaad G Kaplan, Wagdi Almishri, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|July 19, 2005
CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitisFeng Zhou, Maureen N Ajuebor, Paul L Beck, et al.
The American Journal of Gastroenterology|May 8, 2013
B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acidRobert P Myers, Mark G Swain, Samuel S Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2007
Profound suppression of chronic hepatitis C following superinfection with hepatitis B virusCarla S Coffin, Patricia M Mulrooney-Cousins, Samuel S Lee, et al.
Frontiers in Immunology|April 12, 2021
The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the MouseWagdi Almishri, Rachelle P Davis, Abdel-Aziz Shaheen, et al.
The American Journal of Pathology|May 26, 2007
CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitisMaureen N Ajuebor, Zenebech Wondimu, Cory M Hogaboam, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
TNF-alpha-secreting monocytes are recruited into the brain of cholestatic miceSteven M Kerfoot, Charlotte D'Mello, Henry Nguyen, et al.
Hepatology Communications|February 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trialDavid Jones, Marco Carbone, Pietro Invernizzi, et al.
The American Journal of Gastroenterology|April 30, 2021
Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United StatesChristina Thornton, Ranjani Somayaji, Michael Parkins, et al.
Brain, Behavior, and Immunity|August 30, 2021
Behavioural adaptations after antibiotic treatment in male mice are reversed by activation of the aryl hydrocarbon receptorFernando A Vicentini, Alexander J Mathews, Quentin J Pittman, et al.
Plos One|April 5, 2018
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomesAbdel-Aziz Shaheen, Gilaad G Kaplan, Wagdi Almishri, et al.
Pageof 14